Announcements Trials
Browse Landscape

Phase

Phase NA 46Phase 2 4Phase 3 3Phase 1/2 2Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Gynecologic 1Breast 1

Conditions

Leukemia, Myeloid, Acute 1Hereditary Breast and Ovarian Cancer Syndrome 1Breast Neoplasms 1Advanced Cancer 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Completed × Palliative Care × Clear all
NCT00260832 2019-09-11

Trial of Decitabine in Patients With Acute Myeloid Leukemia

Eisai Inc.

Phase 3 Completed
485 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00685256 2017-05-17

Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children

Georgetown University

Phase 3 Completed
245 enrolled
BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed
700 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡